We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




First-Of-Its-Kind Surgical Technology Platform Fuses Light Field Imaging Technology with AI

By HospiMedica International staff writers
Posted on 17 Oct 2023
Print article
Image: The AI-driven technology platform has been used to perform the world`s first light field-enabled spine surgery (Photo courtesy of Proprio)
Image: The AI-driven technology platform has been used to perform the world`s first light field-enabled spine surgery (Photo courtesy of Proprio)

For the first time, an artificial intelligence (AI)--powered surgical navigation system that leverages light field technology to offer real-time 3D views of surgical procedures has been successfully used in humans.

Proprio (Seattle, WA, USA) has announced the successful first-in-human use of its surgical technology platform, Paradigm, which combines light field imaging technology with AI to provide surgical teams with 3D visualization of the anatomical structures as well as surgical environment. Through an assortment of sophisticated sensors and cameras, the system captures high-quality multimodal images during surgery. These images are then integrated with scans taken before the operation to offer surgeons a real-time map of the anatomical structures. This marks an advancement over existing methods, which often involve expensive and radiation-heavy scans that can interrupt the workflow in a clinical setting.

The Paradigm system addresses a variety of pain points commonly encountered in surgical settings. For instance, it minimizes radiation exposure, enhances workflow efficiency, expedites the patient registration process, and continuously collects data. The platform gathers extensive preoperative and intraoperative data to assist in future surgical planning, thereby elevating the precision and efficacy of surgical procedures. Paradigm has received FDA 510(k) clearance and is now being introduced in select hospitals both in the United States and internationally.

"The successful first-in-human use of Paradigm marks a pivotal milestone in our journey to enhance the future of surgery," said Gabriel Jones, CEO and co-founder of Proprio. "We are honored by this validation of the potential of our platform to reshape surgical practices and drive meaningful reductions in costs, increasing access to essential healthcare."

Related Links:
Proprio 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Monitor Arm
ITD Flexion
New
Ultrasound Needle Guide
Ultra-Pro 3

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.